Mobile App-assisted Behavioral Treatment in Children and Adolescents With Tics
Launched by AARHUS UNIVERSITY HOSPITAL · May 22, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new mobile app that helps children and adolescents with tic disorders, such as Tourette syndrome or chronic motor/vocal tics. Tics are sudden movements or sounds that can be distressing, and this study aims to see if using the app, along with behavioral training, can improve tic management more effectively than just providing educational materials. The training includes techniques known to help with tics, and the trial will compare the effectiveness of app-assisted training to a single session of education about tics.
To be eligible for this trial, participants should be between the ages of 3 and 17 and have a diagnosis of a tic disorder with a certain level of severity. They should not have serious mental health issues, such as severe depression or eating disorders, and should not have participated in similar tic training in the past six months. Those who join the study can expect to receive either the app-assisted training or educational resources, and their tic severity will be monitored throughout the process. This research hopes to provide valuable insights into how digital tools can support children and their families in managing tics more effectively.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • a primary diagnosis of a chronic motor/vocal tics disorder including Tourette syndrome according to the WHO ICD-10 diagnostic criteria and Statistical Manual of Mental Disorders
- • a total tic score higher than 13 on the Yale Global Tic Severity Scale (YGTSS), or above a tic score of 9, if only motor or vocal tics are present
- Exclusion Criteria:
- • psychotic disorder
- • primary severe depression
- • suicidal ideation or attempts
- • primary severe eating disorder
- • IQ below 70 (mental retardation)
- • participation in tic training based on HRT/ERP treatment within 6 months
About Aarhus University Hospital
Aarhus University Hospital is a leading research institution in Denmark, dedicated to advancing medical science and improving patient care through innovative clinical trials. As a key sponsor of clinical research, the hospital integrates cutting-edge technology and multidisciplinary expertise to conduct studies that address critical health challenges. With a commitment to ethical standards and patient safety, Aarhus University Hospital collaborates with a diverse network of academic and industry partners, ensuring that its research initiatives contribute to the global body of medical knowledge and enhance treatment options for patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Aarhus N, Risskov, Denmark
Patients applied
Trial Officials
Per Thomsen, Phd
Study Chair
Department of Child and Adolescent Psychiatry, Aarhus University Hospital, Psychiatry, Aarhus, Denmark
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials